Offerings // XTL BIOPHARMACEUTICALS LTD

XTLB offering history

Every offering-related filing in XTL BIOPHARMACEUTICALS LTD’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 545 filings back to Nov 17, 2004.

Last executed offering

Feb 22, 2017

424B5 — priced deal (shares or notes)

Last registration (announced)

Feb 28, 2018

F-1/A — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jun 9, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 7, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 7, 2018	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 6, 2018	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 28, 2018	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Feb 1, 2018	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Feb 22, 2017	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 8, 2016	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Dec 31, 2015	F-1 →	REGISTERED	F-1 registration — capacity to sell shares, not a sale yet
Apr 1, 2015	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 26, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 26, 2014	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Apr 4, 2014	F-3/A →	REGISTERED	F-3/A registration — capacity to sell shares, not a sale yet
Apr 4, 2014	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 2, 2014	F-3/A →	REGISTERED	F-3/A registration — capacity to sell shares, not a sale yet
Mar 5, 2014	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Oct 4, 2012	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 19, 2010	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 11, 2008	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 5, 2008	F-3/A →	REGISTERED	F-3/A registration — capacity to sell shares, not a sale yet
Aug 15, 2008	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Nov 20, 2007	F-3/A →	REGISTERED	F-3/A registration — capacity to sell shares, not a sale yet
Nov 20, 2007	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 13, 2007	F-3/A →	REGISTERED	F-3/A registration — capacity to sell shares, not a sale yet
Oct 30, 2007	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Mar 29, 2007	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 28, 2007	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 23, 2007	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
May 23, 2006	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 22, 2006	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 21, 2006	F-1 →	REGISTERED	F-1 registration — capacity to sell shares, not a sale yet
Jul 7, 2005	RW →	WITHDRAWN	Registration withdrawn

XTLB offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full XTLB workspace →

XTLB offering FAQ

When did XTLB last execute an offering?

Per SEC filings, XTL BIOPHARMACEUTICALS LTD's most recent priced offering document is a 424B5 filed 2017-02-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did XTLB last announce or register an offering?

The most recent registration is a F-1/A filed 2018-02-28. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.